Wegovy vs. Mounjaro: Which Weight Loss Injection is Right for You?

Key Takeaways:

• Wegovy (semaglutide) and Mounjaro (tirzepatide) are both injectable medications for chronic weight management, prescribed weekly.
• Wegovy targets GLP-1 receptors, while Mounjaro targets both GLP-1 and GIP receptors, potentially leading to greater weight loss.
• Clinical trials show Mounjaro typically achieves higher average weight loss percentages compared to Wegovy.
• Common side effects for both include gastrointestinal issues like nausea, vomiting, and diarrhea.
• Choosing the right medication depends on individual health factors, weight loss goals, and doctor consultation.

In the evolving landscape of weight management, injectable medications like Wegovy and Mounjaro have emerged as game-changers for individuals struggling with obesity or overweight conditions with comorbidities. These treatments offer a new pathway to significant weight loss beyond traditional diet and exercise. But with two powerful options, how do you decide which is best for you?

Hi Doctor AI understands the importance of convenient, expert medical advice. Our platform connects you with EU-licensed doctors who can help you navigate these choices, providing consultations and valid prescriptions from the comfort of your home.

Understanding How They Work: GLP-1 vs. Dual Action

Both Wegovy and Mounjaro are designed to help regulate appetite and food intake, but they do so through slightly different mechanisms.

Wegovy (Semaglutide)

Wegovy is the brand name for semaglutide, approved for chronic weight management in adults. It belongs to a class of drugs called GLP-1 receptor agonists. GLP-1 (Glucagon-Like Peptide-1) is a natural hormone that plays a crucial role in appetite regulation and glucose metabolism. When you eat, GLP-1 is released from your gut, signaling to your brain that you're full, slowing down gastric emptying, and stimulating insulin release.

By mimicking the action of natural GLP-1, Wegovy helps you feel fuller for longer, reduces cravings, and ultimately leads to decreased calorie intake and weight loss. It's administered as a once-weekly subcutaneous injection, with dosages gradually increased over several weeks to minimize side effects.

Mounjaro (Tirzepatide)

Mounjaro, or tirzepatide, represents a newer generation of weight loss medication. It's unique because it's a dual GIP (Glucose-dependent Insulinotropic Polypeptide) and GLP-1 receptor agonist. This means it activates receptors for two different incretin hormones, GIP and GLP-1, which are naturally released by the intestine after eating.

The dual action of Mounjaro provides a more comprehensive approach to appetite and glucose control. Like GLP-1, GIP also helps regulate blood sugar and can contribute to feelings of fullness. By activating both pathways, Mounjaro offers potentially enhanced effects on appetite suppression, improved insulin sensitivity, and significant weight reduction. Mounjaro is also administered as a once-weekly subcutaneous injection, with dosage escalation over time.

Efficacy and Expected Weight Loss: What Do the Studies Say?

Comparing the efficacy of Wegovy and Mounjaro is often a key factor for individuals considering these treatments. Clinical trials have provided valuable insights into their weight loss potential.

Wegovy Clinical Trial Results

In the STEP (Semaglutide Treatment Effect in People with Obesity) clinical trials, participants using Wegovy achieved an average weight loss of approximately 15-17% of their initial body weight over 68 weeks. This was significantly higher than the placebo group, which saw about 2.4% weight loss. Many participants achieved a 5% or more weight loss, which is considered clinically meaningful for improving health markers.

Mounjaro Clinical Trial Results

Mounjaro's SURMOUNT clinical trials demonstrated even more impressive weight loss outcomes. Participants using the highest dose of Mounjaro (15mg) achieved an average weight loss of up to 22.5% of their initial body weight over 72 weeks. Lower doses also showed substantial weight loss, with 5mg achieving around 15% and 10mg achieving about 19.5%. These results suggest Mounjaro may offer a greater magnitude of weight loss for some individuals.

It's important to remember that individual results can vary based on factors like adherence to treatment, diet, exercise, and individual physiological responses.

Potential Side Effects and Considerations

While highly effective, both Wegovy and Mounjaro come with potential side effects, primarily gastrointestinal in nature. Understanding these can help you prepare and discuss them with your doctor.

Common Side Effects (Both Medications)

• Nausea: Often the most common side effect, especially during dose escalation.
• Vomiting: Can occur, particularly if doses are increased too quickly.
• Diarrhea or Constipation: Digestive changes are frequent.
• Abdominal Pain: Mild to moderate discomfort.
• Indigestion/Heartburn: Some individuals may experience these.

These side effects are generally mild to moderate and tend to decrease over time as your body adjusts to the medication. Gradual dose escalation is a strategy used to help mitigate these effects.

Serious Side Effects (Rare but Important)

Both drugs carry warnings for more serious, though rare, side effects:

• Pancreatitis: Inflammation of the pancreas.
• Gallbladder problems: Including gallstones.
• Thyroid C-cell tumors: Observed in animal studies; it's unknown if they cause these in humans. Therefore, they are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
• Kidney problems: Worsening of kidney function in people with existing kidney disease.
• Hypoglycemia: Low blood sugar, especially if used with other diabetes medications like insulin or sulfonylureas.

It is crucial to discuss your full medical history with an EU-licensed doctor to ensure these medications are safe and appropriate for you.

Choosing the Right Path with Hi Doctor AI

Deciding between Wegovy and Mounjaro is a personal medical decision that should be made in consultation with a qualified healthcare professional. Factors to consider include:

• Your weight loss goals: Mounjaro may offer higher average weight loss.
• Tolerance to side effects: While similar, individual responses can vary.
• Medical history: Pre-existing conditions or family history may contraindicate one medication over another.
• Cost and availability: These can vary, and your doctor can advise on what's accessible.

Hi Doctor AI offers a convenient and confidential way to explore these options. Our EU-licensed doctors are experienced in weight management treatments and can provide a personalized assessment. You can complete an online consultation, and if suitable, receive a valid prescription within 24 hours, all for a 45€ consultation fee. If a prescription isn't issued, you receive a full refund.

Hi Doctor AI provides telemedicine consultations. All treatments are prescribed by EU-licensed doctors after reviewing your medical history. We do not sell or ship medications—prescriptions can be used at any licensed pharmacy in the EU.

Ready to start your weight loss journey? Get your online consultation with Hi Doctor AI—EU-licensed doctors, 45€ consultation fee.